Physician profile
John R Tompkins
NPI 1265453617
$881.57
in general payments reported to CMS, 2019-2025
7 companies · $13.49 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $175 · 2022: $11.70 · 2023: $237 · 2024: $53.97 · 2025: $13.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $332.25 | 2019-2023 | Nucala, Arexvy |
| Irras USA, INC. | $179.44 | 2019 | |
| Penumbra, INC. | $162.36 | 2020 | |
| Medtronic USA, INC. | $115.98 | 2019 | |
| Biotronik Nro, INC. | $39.84 | 2024 | Prospera |
| Integra Lifesciences Corporation | $37.57 | 2020-2025 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Theragen, INC. | $14.13 | 2024 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tompkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.